- Ombudsman and campaigners attack "dilution" of EMA data disclosure policy
- EMA rejects claims of undue industry influence on data disclosure policy
- EU reveals proposals on pharma in TTIP talks
- US Capitol Capsule: Rare disease sector matures; FDA keeping pace?
- PROFILE: Vas Narasimhan on many Novartis roles, extinction fears and Hilleman influences
- Profile: The ABPI's reimbursement director on Pfizer, his TicTac salary, and paper mache
JOB OF THE WEEK Promote your job vacancy